- Home
- NGL vs EBS Comparison
NGL vs EBS Comparison
Compare NGL & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGL | EBS |
|---|---|---|
| Founded | 1940 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 751.7M | 663.3M |
| IPO Year | 2011 | 2006 |
Fundamental Metrics
Financial Performance| Metric | NGL | EBS |
|---|---|---|
| Price | $9.78 | $12.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 253.8K | ★ 821.2K |
| Earning Date | 02-09-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $3,250,313,000.00 | $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | ★ N/A | $9.01 |
| Revenue Growth | ★ 46.95 | N/A |
| 52 Week Low | $2.64 | $4.02 |
| 52 Week High | $10.29 | $14.06 |
Technical Indicators
Market Signals| Indicator | NGL | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 51.58 |
| Support Level | $8.62 | $11.54 |
| Resistance Level | $10.04 | $14.06 |
| Average True Range (ATR) | 0.37 | 0.59 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 72.44 | 34.92 |
Price Performance
Historical ComparisonAbout NGL NGL ENERGY PARTNERS LP
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.